25 results
8-K
EX-99.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
of the brain. Inhibikase is headquartered in Atlanta, Georgia with offices in Lexington, Massachusetts.
Social Media Disclaimer
Investors and others should
8-K
EX-99.1
IKT
Inhibikase Therapeutics Inc
18 Apr 24
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
9:46pm
cognitive and motor function diseases of the brain. Inhibikase is headquartered in Atlanta, Georgia with offices in Lexington, Massachusetts.
Social
8-K
EX-99.1
IKT
Inhibikase Therapeutics Inc
7 Feb 24
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA
7:59am
is headquartered in Atlanta, Georgia with an office in Lexington, Massachusetts.
Social Media Disclaimer
Investors and others should note that we announce
8-K
EX-10.1
xe9vmigbxz32
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-99.1
qs9xczx
16 Jan 24
Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli
4:31pm
8-K
EX-99.1
14r6kd8 i79
20 Sep 23
Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity
11:23am
8-K
EX-99.2
myxbtu 0pgm6b
17 Jul 23
Other Events
5:29pm
8-K
EX-99.1
ydt7 a3xjwlqevd
29 Jun 23
Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split
12:15pm
424B3
i1qhvjou7r slnbn7hr
4 Apr 23
Prospectus supplement
4:57pm
POS AM
yeyd tawlxna
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-99.1
tsokibzp8o
17 Nov 22
Inhibikase Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity
4:30pm
8-K
EX-99.1
0gx fh3uw1rzb451crc
7 Nov 22
Inhibikase Therapeutics Announces FDA Clinical Hold on IkT-148009 Programs
4:01pm
8-K
EX-99.1
b5jeo5lii8opu39mm
1 Sep 22
Inhibikase Therapeutics Appoints Gisele Dion to Board of Directors
5:30pm
8-K
EX-10.1
cecsvple5u9c8ipg
16 May 22
Entry into a Material Definitive Agreement
9:49pm
8-K
EX-99.1
ymk009fwm47
21 Jun 21
Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock
9:23am